| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY | 2021-06-30 FY | 2021-03-31 FY |
|---|---|---|---|---|---|---|---|
| Revenue | – | – | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – | – |
| Operating Expenses | – | $260.03M | $240.49M | $140.78M | $136.04M | – | – |
| R&D | – | – | – | – | – | – | – |
| SG&A | – | – | – | – | – | – | – |
| Operating Income | – | – | – | – | – | – | – |
| Interest Expense | $101.00M | $105.16M | $133.73M | $62.99M | $38.83M | – | – |
| Tax Expense | – | $3.94M | $2.37M | $2.62M | $384.00K | – | – |
| Net Income | $170.52M | $186.57M | $222.02M | $108.05M | $41.82M | $58.35M | $56.65M |
| EPS (basic) | 1.8100 | 2.0300 | 2.6100 | 1.3800 | 2.9300 | – | – |
| EPS (diluted) | 1.8100 | 2.0300 | 2.6100 | 1.3800 | 2.7900 | – | – |
| Shares (diluted) | $94.10M | $92.04M | $85.13M | $78.20M | $77.70M | – | – |